OptimizeRx
OPRX
OPRX
98 hedge funds and large institutions have $180M invested in OptimizeRx in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 30
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.29% less ownership
Funds ownership: 78.55% → 69.26% (-9.3%)
Holders
98
Holding in Top 10
1
Calls
$3.87M
Puts
$489K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$1.92M | |
| 3 | +$1.55M | |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
+$1.38M |
| 5 |
Renaissance Technologies
New York
|
+$1.32M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$3.14M | |
| 3 | -$2.36M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.35M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.97M |